TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025
Seeking Alpha / 11 hours ago 1 Views
Seeking Alpha / 11 hours ago 1 Views
TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox
Comments